Show simple item record

dc.contributor.authorGarcia, Santiago
dc.contributor.authorRade, Jeffrey J.
dc.date2022-08-11T08:08:11.000
dc.date.accessioned2022-08-23T15:45:54Z
dc.date.available2022-08-23T15:45:54Z
dc.date.issued2020-08-07
dc.date.submitted2020-08-13
dc.identifier.citation<p>Garcia S, Stanberry L, Schmidt C, Sharkey S, Megaly M, Albaghdadi MS, Meraj PM, Garberich R, Jaffer FA, Stefanescu Schmidt AC, Dixon SR, Rade JJ, Smith T, Tannenbaum M, Chambers J, Aguirre F, Huang PP, Kumbhani DJ, Koshy T, Feldman DN, Giri J, Kaul P, Thompson C, Khalili H, Maini B, Nayak KR, Cohen MG, Bangalore S, Shah B, Henry TD. Impact of COVID-19 pandemic on STEMI care: An expanded analysis from the United States. Catheter Cardiovasc Interv. 2020 Aug 7. doi: 10.1002/ccd.29154. Epub ahead of print. PMID: 32767652. <a href="https://doi.org/10.1002/ccd.29154">Link to article on publisher's site</a></p>
dc.identifier.issn1522-1946 (Linking)
dc.identifier.doi10.1002/ccd.29154
dc.identifier.pmid32767652
dc.identifier.urihttp://hdl.handle.net/20.500.14038/27635
dc.description<p>Full author list omitted for brevity. For the full list of authors, see article.</p>
dc.description.abstractOBJECTIVE: To evaluate the impact of COVID-19 pandemic migitation measures on of ST-elevation myocardial infarction (STEMI) care. BACKGROUND: We previously reported a 38% decline in cardiac catheterization activations during the early phase of the COVID-19 pandemic mitigation measures. This study extends our early observations using a larger sample of STEMI programs representative of different US regions with the inclusion of more contemporary data. METHODS: Data from 18 hospitals or healthcare systems in the US from January 2019 to April 2020 were collecting including number activations for STEMI, the number of activations leading to angiography and primary percutaneous coronary intervention (PPCI), and average door to balloon (D2B) times. Two periods, January 2019-February 2020 and March-April 2020, were defined to represent periods before (BC) and after (AC) initiation of pandemic mitigation measures, respectively. A generalized estimating equations approach was used to estimate the change in response variables at AC from BC. RESULTS: Compared to BC, the AC period was characterized by a marked reduction in the number of activations for STEMI (29%, 95% CI:18-38, p < .001), number of activations leading to angiography (34%, 95% CI: 12-50, p = .005) and number of activations leading to PPCI (20%, 95% CI: 11-27, p < .001). A decline in STEMI activations drove the reductions in angiography and PPCI volumes. Relative to BC, the D2B times in the AC period increased on average by 20%, 95%CI (-0.2 to 44, p = .05). CONCLUSIONS: The COVID-19 Pandemic has adversely affected many aspects of STEMI care, including timely access to the cardiac catheterization laboratory for PPCI.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=32767652&dopt=Abstract">Link to Article in PubMed</a></p>
dc.relation.urlhttps://doi.org/10.1002/ccd.29154
dc.subjectCOVID-19
dc.subjectST-elevation myocardial infarction
dc.subjectSTEMI
dc.subjectCardiology
dc.subjectCardiovascular Diseases
dc.subjectInfectious Disease
dc.subjectVirus Diseases
dc.titleImpact of COVID-19 pandemic on STEMI care: An expanded analysis from the United States
dc.typeJournal Article
dc.source.journaltitleCatheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography and Interventions
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1088&amp;context=covid19&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/covid19/86
dc.identifier.contextkey18900234
refterms.dateFOA2022-08-23T15:45:54Z
html.description.abstract<p>OBJECTIVE: To evaluate the impact of COVID-19 pandemic migitation measures on of ST-elevation myocardial infarction (STEMI) care.</p> <p>BACKGROUND: We previously reported a 38% decline in cardiac catheterization activations during the early phase of the COVID-19 pandemic mitigation measures. This study extends our early observations using a larger sample of STEMI programs representative of different US regions with the inclusion of more contemporary data.</p> <p>METHODS: Data from 18 hospitals or healthcare systems in the US from January 2019 to April 2020 were collecting including number activations for STEMI, the number of activations leading to angiography and primary percutaneous coronary intervention (PPCI), and average door to balloon (D2B) times. Two periods, January 2019-February 2020 and March-April 2020, were defined to represent periods before (BC) and after (AC) initiation of pandemic mitigation measures, respectively. A generalized estimating equations approach was used to estimate the change in response variables at AC from BC.</p> <p>RESULTS: Compared to BC, the AC period was characterized by a marked reduction in the number of activations for STEMI (29%, 95% CI:18-38, p < .001), number of activations leading to angiography (34%, 95% CI: 12-50, p = .005) and number of activations leading to PPCI (20%, 95% CI: 11-27, p < .001). A decline in STEMI activations drove the reductions in angiography and PPCI volumes. Relative to BC, the D2B times in the AC period increased on average by 20%, 95%CI (-0.2 to 44, p = .05).</p> <p>CONCLUSIONS: The COVID-19 Pandemic has adversely affected many aspects of STEMI care, including timely access to the cardiac catheterization laboratory for PPCI.</p>
dc.identifier.submissionpathcovid19/86
dc.contributor.departmentDepartment of Medicine, Division of Cardiovascular Medicine


Files in this item

Thumbnail
Name:
ccd.29154.pdf
Size:
2.331Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record